Trade Mark Journal No.2026/021 22 May 2026
WO0000001916528 (9,44)
Office of origin: Canada
Date of International Registration:10 March 2026
Date of designation in the UK:
10 March 2026
International priority date claimed: 11 September 2025
(Canada)
(2423691)
- Class 9
- Computer software for medical imaging; downloadable and recorded computer software for medical diagnostic imaging for use in diagnosis and treatment of bowel inflammatory diseases and conditions; recorded and downloadable computer software for monitoring and managing patient medical records; clinical decision support software and application; software as a medical device [SaMD], downloadable, for processing and analysis of ultrasound images for medical diagnostic imaging; computer software for monitoring patient medical information computer software for monitoring patient medical information; computer software for use in testing, monitoring, research, analysis and assessment of inflammatory bowel diseases for medical purposes and for purposes of conducting clinical trials; downloadable web application software for use in search and reference of medical conditions for medical diagnostic services; computer software featuring artificial intelligence for use with pattern discovery, recognition, classification, segmentation and visualization of medical data.
- Class 44
- Providing medical information and advice in the field of inflammatory bowel disease and gastroenterology; providing information concerning the use of medical diagnostic imaging equipment by means of a web site; information, advisory and consultancy services in the field of prevention and treatment of gastro-intestinal disorders; information, advisory and consultancy services in the field of medical care, analysis services and medical treatment services; providing information for patients and healthcare professionals in the field of gastro-intestinal disorders via a website; medical imaging services and medical screening; medical and health care services in the field of gastro-intestinal disorders; bowel cancer screening services; medical care and analysis services relating to patient treatment; medical clinic services; medical analysis services for the diagnosis of inflammatory bowel diseases; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis services for inflammatory bowel diseases diagnosis and prognosis; consulting and services provider for providing medical information in the field of artificial intelligence based medical devices for pattern discovery, recognition, classification, segmentation, and visualization of medical data; consulting and services provider for providing medical information in the field of software products for pattern discovery, recognition, classification, segmentation, and visualization of medical data.
Dova Health Intelligence Inc.
Representative: MLT AIKINS LLP, 2100 Livingston Place, 222-3rd Avenue SW, Calgary AB T2P 0B4, CANADA